157 related articles for article (PubMed ID: 25401297)
1. BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.
Neuendorff NR; Schwarz M; Hemmati P; Türkmen S; Bommer C; Burmeister T; Dörken B; le Coutre P; Arnold R; Westermann J
Acta Haematol; 2015; 133(2):237-41. PubMed ID: 25401297
[TBL] [Abstract][Full Text] [Related]
2. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
[TBL] [Abstract][Full Text] [Related]
3. Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.
Hochhaus A; Mahon FX; le Coutre P; Petrov L; Janssen JJWM; Cross NCP; Rea D; Castagnetti F; Hellmann A; Rosti G; Gattermann N; Coronel MLP; Gutierrez MAE; Garcia-Gutierrez V; Vincenzi B; Dezzani L; Giles FJ
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1225-1233. PubMed ID: 28224300
[TBL] [Abstract][Full Text] [Related]
4. Secondary acquisition of BCR-ABL1 fusion in de novo GATA2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
[TBL] [Abstract][Full Text] [Related]
5. Acute Megakaryoblastic Leukemia Harboring a Subclone Expressing BCR-ABL1 Fusion Gene Product.
Kashima E; Nakano E; Watanabe Y; Imai H; Oka K; Kageyama S; Tanaka I
Intern Med; 2021 Nov; 60(22):3609-3614. PubMed ID: 34053988
[TBL] [Abstract][Full Text] [Related]
6. The Philadelphia chromosome in leukemogenesis.
Kang ZJ; Liu YF; Xu LZ; Long ZJ; Huang D; Yang Y; Liu B; Feng JX; Pan YJ; Yan JS; Liu Q
Chin J Cancer; 2016 May; 35():48. PubMed ID: 27233483
[TBL] [Abstract][Full Text] [Related]
7. Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.
Kim TD; Türkmen S; Schwarz M; Koca G; Nogai H; Bommer C; Dörken B; Daniel P; le Coutre P
Haematologica; 2010 Apr; 95(4):582-8. PubMed ID: 20015884
[TBL] [Abstract][Full Text] [Related]
8. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
[TBL] [Abstract][Full Text] [Related]
9. Optimal Response in a Patient With CML Expressing
Manzella L; Tirrò E; Vitale SR; Puma A; Consoli ML; Tambè L; Pennisi MS; DI Gregorio S; Romano C; Tomarchio C; DI Raimondo F; Stagno F
In Vivo; 2020; 34(3):1481-1486. PubMed ID: 32354950
[TBL] [Abstract][Full Text] [Related]
10. Does BCR/ABL1 positive acute myeloid leukaemia exist?
Nacheva EP; Grace CD; Brazma D; Gancheva K; Howard-Reeves J; Rai L; Gale RE; Linch DC; Hills RK; Russell N; Burnett AK; Kottaridis PD
Br J Haematol; 2013 May; 161(4):541-50. PubMed ID: 23521501
[TBL] [Abstract][Full Text] [Related]
11. BCR-ABL1 positive AML or CML in blast crisis? A pediatric case report with inv(3) and t(9;22) in the initial clone.
Behrens YL; Schienke A; Davenport C; Lentes J; Tauscher M; Steinemann D; Rasche M; Knirsch S; Joachim S; Reinhardt D; Schlegelberger B; Göhring G
Cancer Genet; 2021 Jun; 254-255():70-74. PubMed ID: 33647814
[TBL] [Abstract][Full Text] [Related]
12. From the archives of MD Anderson Cancer Center: Concurrent BCR-ABL1 and CRLF2 rearrangements in B-lymphoblast phase of chronic myeloid leukemia.
Thakral B; Jain N; Tang G; Konoplev S; Vega F; Medeiros LJ; Wang SA
Ann Diagn Pathol; 2021 Aug; 53():151767. PubMed ID: 34118580
[TBL] [Abstract][Full Text] [Related]
13. Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial.
Kantarjian HM; Hochhaus A; Saglio G; De Souza C; Flinn IW; Stenke L; Goh YT; Rosti G; Nakamae H; Gallagher NJ; Hoenekopp A; Blakesley RE; Larson RA; Hughes TP
Lancet Oncol; 2011 Sep; 12(9):841-51. PubMed ID: 21856226
[TBL] [Abstract][Full Text] [Related]
14. High reliability and sensitivity of the BCR/ABL1 D-FISH test for the detection of BCR/ABL rearrangements.
Pelz AF; Kröning H; Franke A; Wieacker P; Stumm M
Ann Hematol; 2002 Mar; 81(3):147-53. PubMed ID: 11904740
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.
Konoplev S; Yin CC; Kornblau SM; Kantarjian HM; Konopleva M; Andreeff M; Lu G; Zuo Z; Luthra R; Medeiros LJ; Bueso-Ramos CE
Leuk Lymphoma; 2013 Jan; 54(1):138-44. PubMed ID: 22691121
[TBL] [Abstract][Full Text] [Related]
16. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up.
Saydam G; Haznedaroglu IC; Kaynar L; Yavuz AS; Ali R; Guvenc B; Akay OM; Baslar Z; Ozbek U; Sonmez M; Aydin D; Pehlivan M; Undar B; Dagdas S; Ayyildiz O; Akin G; Dag IM; Ilhan O
Hematology; 2018 Dec; 23(10):771-777. PubMed ID: 29996726
[TBL] [Abstract][Full Text] [Related]
17. Molecular and phenotypic analysis of Philadelphia chromosome-positive bilineage leukemia: possibility of a lineage switch from T-lymphoid leukemic progenitor to myeloid cells.
Monma F; Nishii K; Ezuki S; Miyazaki T; Yamamori S; Usui E; Sugimoto Y; Lorenzo V F; Katayama N; Shiku H
Cancer Genet Cytogenet; 2006 Jan; 164(2):118-21. PubMed ID: 16434313
[TBL] [Abstract][Full Text] [Related]
18. Prolonged survival with imatinib mesylate combined with chemotherapy and allogeneic stem cell transplantation in de novo Ph+ acute myeloid leukemia.
Sun J; Wang Z; Luo Y; Tan Y; Allan DS; Huang H
Acta Haematol; 2012; 127(3):143-8. PubMed ID: 22248505
[TBL] [Abstract][Full Text] [Related]
19. Philadelphia-positive acute lymphoblastic leukemia with multiple subclones including duplication of the Philadelphia chromosome and Abelson oncogene.
La Starza R; Vitale A; Serra A; Saglio G; Fioritoni G; Falzetti D; Martelli MF; Foà R; Mecucci C
Cancer Genet Cytogenet; 2002 Jan; 132(1):46-50. PubMed ID: 11801308
[TBL] [Abstract][Full Text] [Related]
20. p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16).
Dai HP; Xue YQ; Wu LL; Pan JL; Gong YL; Wu YF; Zhang J; Wu DP; Chen SN
Int J Hematol; 2012 Dec; 96(6):814-7. PubMed ID: 23054652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
